Trial NCT02937766

View at ClinicalTrials.gov 
Org. Study IDs: AMAG-HPC-HPM-301

Last trial update was posted on 2022-04-21

MeSH Interventions

11-hydroxyprogesterone 17 alpha-Hydroxyprogesterone Caproate

MeSH Conditions


Other Conditions

Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) in Healthy Post-menopausal Women

Stopping Reasons

The Sponsor elected to discontinue the study prematurely due to business reasons

Limitations And Caveats

The Sponsor elected to discontinue the study prematurely due to business reasons. The only parameters analyzed for efficacy were Ease of Drug Preparation and Ease of Injection Technique.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID